We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $51.78 · 27 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Medline details its Prime vendor model expansion into Canada - Digital Commerce 360
Medline details its Prime vendor model expansion into Canada Digital Commerce 360
Medline's Prime Vendor model expands outside the United States - PR Newswire
Medline's Prime Vendor model expands outside the United States PR Newswire
First Medline Canada deal to run hospital supply chains in Ontario - Stock Titan
First Medline Canada deal to run hospital supply chains in Ontario Stock Titan
Medline closes secondary offering of 72.6 million shares at $37 - Investing.com
Medline closes secondary offering of 72.6 million shares at $37 Investing.com
Medline Announces Closing Of Upsized Secondary Offering Of Class A Common Stock - TradingView
Medline Announces Closing Of Upsized Secondary Offering Of Class A Common Stock TradingView
Blackstone-linked holders sell 72,554,594 Medline shares at $37 - Stock Titan
Blackstone-linked holders sell 72,554,594 Medline shares at $37 Stock Titan
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 05. | After market close (AMC) | $0.32 | — | — | $7.52B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 29. | Time TBD | — | $0.16 | — | — | $6.64B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 15. | BNP Paribas | — | Maintain | Neutral → Neutral | — | BNP Paribas: Neutral |
| 2026. 05. 14. | Tigress Financial | — | Maintain | Buy → Buy | — | Tigress Financial: Buy |
| 2026. 05. 08. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 05. 07. | Bernstein | — | Maintain | Outperform → Outperform | — | Bernstein: Outperform |
| 2026. 05. 07. | BTIG | — | Maintain | Buy → Buy | — | BTIG: Buy |
| 2026. 03. 11. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 3,304,305 | $147.04B | 0.27% | — | New position |
| 2 | SOROS FUND MANAGEMENT LLC | SOROS FUND MANAGEMENT LLC | 1,580,000 | $66.36B | 1.18% | — | New position |
| 3 | SOROS FUND MANAGEMENT LLC | SOROS FUND MANAGEMENT LLC | 1,286,434 | $57.25B | 1.04% | — | New position |
| 4 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 1,138,548 | $50.67B | 0.04% | — | New position |
| 5 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 891,100 | $37.43B | 0.06% | — | New position |
| 6 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 6,500 | $273M | 0.00% | — | New position |